Kurovent (Formoterol Fumarate Dihydrate)

• Formoterol fumarate dihydrate, a long‑acting β2‑adrenergic agonist, is used to manage obstructive airway diseases.
• Asthma: improves symptom control and reduces the frequency of exacerbations.
• COPD: enhances lung function and decreases breathlessness during daily activities.
• Maintenance therapy: provides long‑acting bronchodilation to reduce reliance on short‑acting rescue inhalers.

• Formoterol binds selectively to β2‑adrenergic receptors on airway smooth‑muscle cells, activating adenylate cyclase and increasing intracellular cyclic AMP. The rise in cAMP leads to relaxation of bronchial smooth muscle, resulting in prolonged bronchodilation and improved airflow in the respiratory tract.

Formoterol may cause a range of adverse reactions, which are categorized by frequency.

Common Side Effects

• Tremor: mild shaking of the hands or limbs.
• Headache: transient cranial discomfort.
• Throat irritation: soreness or dryness after inhalation.
• Cough: brief irritation leading to coughing.
• Palpitations: sensation of rapid or irregular heartbeat.
• Muscle cramps: occasional limb discomfort.

Serious or Rare Side Effects

• Paradoxical bronchospasm: sudden worsening of breathing.
• Cardiac arrhythmia: abnormal heart rhythm that may require medical attention.
• Severe hypokalemia: markedly low blood potassium levels.
• Anaphylaxis: life‑threatening allergic reaction.
• Chest pain: persistent discomfort that could indicate cardiac issues.
• Tachycardia: sustained rapid heart rate.

• Before prescribing or using Kurovent, clinicians should consider several safety measures.
• Assess cardiovascular status: evaluate for underlying heart disease.
• Monitor for worsening asthma: ensure patients have an action plan.
• Avoid in patients with known hypersensitivity: discontinue if allergic reaction occurs.
• Use with caution in patients on beta‑blockers: may reduce efficacy.
• Educate on correct inhaler technique: improper use can diminish therapeutic effect.
• Store at room temperature: keep in original packaging, protect from moisture and heat.

Formoterol can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

• Non‑selective β‑blockers: may antagonize bronchodilatory effect.
• Other long‑acting β2‑agonists: risk of additive cardiovascular stimulation.
• Certain diuretics (e.g., thiazides): can exacerbate hypokalemia.
• Monoamine oxidase inhibitors: potential for enhanced sympathomimetic effects.
• Anticholinergic agents: may increase risk of cardiac events.

Moderate Interactions (Monitor Closely)

• Inhaled corticosteroids: monitor for synergistic bronchodilation.
• Theophylline: observe for altered plasma concentrations.
• Anticholinergic bronchodilators: assess combined respiratory effects.
• ACE inhibitors: watch for cough augmentation.
• Diuretics (loop): monitor electrolyte balance.